These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27227290)

  • 21. Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.
    Nørgaard K; Shin J; Welsh JB; Gjessing H
    J Diabetes Sci Technol; 2015 Mar; 9(2):215-20. PubMed ID: 25591857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.
    Zisser H
    Diabetes Care; 2008 Feb; 31(2):238-9. PubMed ID: 18056889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system.
    Overland J; Molyneaux L; Tewari S; Fatouros R; Melville P; Foote D; Wu T; Yue DK
    Diabetes Obes Metab; 2009 May; 11(5):460-3. PubMed ID: 19236441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique.
    Simic A; Schøndorff PK; Stumpe T; Heschel M; Regittnig W; Pöttler T; Ninaus D; Augustin T; Groselj-Strele A; Pieber TR; Mader JK
    Diabetes Obes Metab; 2021 Jun; 23(6):1402-1408. PubMed ID: 33528887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home.
    Blauw H; van Bon AC; Koops R; DeVries JH;
    Diabetes Obes Metab; 2016 Jul; 18(7):671-7. PubMed ID: 26996542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local lipohypertrophy in insulin treatment].
    Herold DA; Albrecht G
    Hautarzt; 1993 Jan; 44(1):40-2. PubMed ID: 8436508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
    Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C
    Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.
    Hoogma RP; Schumicki D
    Horm Metab Res; 2006 Jun; 38(6):429-33. PubMed ID: 16823727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes.
    Kastner JR; Venkatesh N; Brown K; Muchmore DB; Ekinci E; Fourlanos S; Joseph JI; Shafeeq M; Shi L; Strange P; Strasma PJ; O'Neal DN
    Diabetes Obes Metab; 2022 Jun; 24(6):1143-1149. PubMed ID: 35257468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient management of long-term continuous subcutaneous insulin infusion.
    Johansson UB; Adamson U; Lins PE; Wredling R
    J Adv Nurs; 2005 Jul; 51(2):112-8. PubMed ID: 15963182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes.
    Cobry E; McFann K; Messer L; Gage V; VanderWel B; Horton L; Chase HP
    Diabetes Technol Ther; 2010 Mar; 12(3):173-7. PubMed ID: 20151766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
    Zisser HC; Bevier WC; Jovanovic L
    Diabetes Technol Ther; 2007 Dec; 9(6):509-15. PubMed ID: 18034605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.
    McVey E; Keith S; Herr JK; Sutter D; Pettis RJ
    J Diabetes Sci Technol; 2015 Aug; 9(6):1282-91. PubMed ID: 26319228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus.
    Rumpler M; Mader JK; Fischer JP; Thar R; Granger JM; Deliane F; Klimant I; Aberer F; Sinner F; Pieber TR; Hajnsek M
    Biosens Bioelectron; 2017 Feb; 88():240-248. PubMed ID: 27554063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans.
    Clausen TS; Kaastrup P; Stallknecht B
    Diabetes Technol Ther; 2009 Sep; 11(9):575-80. PubMed ID: 19764836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time continuous glucose monitoring together with telemedical assistance improves glycemic control and glucose stability in pump-treated patients.
    Rigla M; Hernando ME; Gómez EJ; Brugués E; García-Sáez G; Capel I; Pons B; de Leiva A
    Diabetes Technol Ther; 2008 Jun; 10(3):194-9. PubMed ID: 18473693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.
    Kastner JR; Eisler G; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Strasma PJ; Joseph JI
    J Diabetes Sci Technol; 2023 Nov; 17(6):1563-1572. PubMed ID: 35533132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.